GRM5 and obesity disorder: In order to assess potential therapeutic applications of mGluR5-targeting drugs in obesity, herein we focused on the role of negative modulation of mGluR5 by VU0409106 in feeding regulation, body weight, binge eating, and adipose tissue inflammation on diet-induced obese mice.